Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest...

